195 related articles for article (PubMed ID: 18044010)
1. The anti-secretory and anti-ulcer activities of esomeprazole in comparison with omeprazole in the stomach of rats and rabbits.
Bastaki SM; Chandranath IS; Singh J
Mol Cell Biochem; 2008 Feb; 309(1-2):167-75. PubMed ID: 18044010
[TBL] [Abstract][Full Text] [Related]
2. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.
Wallmark B; Lorentzon P; Larsson H
Scand J Gastroenterol Suppl; 1985; 108():37-51. PubMed ID: 2988109
[TBL] [Abstract][Full Text] [Related]
4. Role of gastric acid secretion in progression of acute gastric erosions induced by ischemia-reperfusion into gastric ulcers.
Brzozowski T; Konturek PC; Konturek SJ; Drozdowicz D; Kwiecieñ S; Pajdo R; Bielanski W; Hahn EG
Eur J Pharmacol; 2000 Jun; 398(1):147-58. PubMed ID: 10856459
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of action of leptin in preventing gastric ulcer.
Adeyemi EO; Bastaki SA; Chandranath IS; Hasan MY; Fahim M; Adem A
World J Gastroenterol; 2005 Jul; 11(27):4154-60. PubMed ID: 16015682
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of acid formation by epidermal growth factor in the isolated rabbit gastric glands.
Dembiński A; Drozdowicz D; Gregory H; Konturek SJ; Warzecha Z
J Physiol; 1986 Sep; 378():347-57. PubMed ID: 3025433
[TBL] [Abstract][Full Text] [Related]
7. Effects of esomeprazole on healing of nonsteroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: Characterization of molecular mechanisms.
Fornai M; Colucci R; Antonioli L; Awwad O; Ugolini C; Tuccori M; Fulceri F; Natale G; Basolo F; Blandizzi C
Pharmacol Res; 2011 Jan; 63(1):59-67. PubMed ID: 20969958
[TBL] [Abstract][Full Text] [Related]
8. Comparison of five antisecretory agents acting via gastric H+/K+-ATPase.
Bastaki SM; Chandranath I; Garner A
J Physiol Paris; 2000; 94(1):19-23. PubMed ID: 10761684
[TBL] [Abstract][Full Text] [Related]
9. Gastric antisecretory activity of lansoprazole in different experimental models: comparison with omeprazole.
Coruzzi G; Adami M; Bertaccini G
Gen Pharmacol; 1995 Sep; 26(5):1027-32. PubMed ID: 7557245
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and pharmacological characteristics of 3-butyryl-8-methoxy-4-[(2-thiophenyl)amino]quinoline, a new proton-pump inhibitor, in rabbit gastric microsomes and in rats.
Kim KB; Chang MS; Chung YK; Sohn SK; Kim SG; Choi WS
J Pharm Pharmacol; 1998 May; 50(5):521-9. PubMed ID: 9643446
[TBL] [Abstract][Full Text] [Related]
11. Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK(B) receptor antagonist.
Makovec F; Revel L; Letari O; Mennuni L; Impicciatore M
Eur J Pharmacol; 1999 Mar; 369(1):81-90. PubMed ID: 10204685
[TBL] [Abstract][Full Text] [Related]
12. Increased hepatocyte growth factor content in rat stomach during omeprazole treatment.
Kinoshita Y; Hassan MS; Kawamura M; Matsushima Y; Okada A; Maekawa T; Fukui H; Waki S; Kishi K; Chiba T
Digestion; 1998; 59(2):102-9. PubMed ID: 9586821
[TBL] [Abstract][Full Text] [Related]
13. Effects of indomethacin, piroxicam and selected prostanoids on gastric acid secretion by the rat isolated gastric mucosa.
Reeves JJ; Stables R
Br J Pharmacol; 1985 Nov; 86(3):677-84. PubMed ID: 2998524
[TBL] [Abstract][Full Text] [Related]
14. Effect of omeprazole on gastric acid secretion by the rat isolated stomach.
Coruzzi G; Adami M; Moretti U; Bertaccini G
Pharmacol Res Commun; 1986 Mar; 18(3):257-71. PubMed ID: 2873595
[TBL] [Abstract][Full Text] [Related]
15. [Effects of omeprazole and famotidine on (H+-K+) ATPase and acid secretion in rabbit gastric glands].
Tomoi M; Itoh H; Ueda S; Ono T; Shibayama F
Nihon Yakurigaku Zasshi; 1988 Aug; 92(2):105-11. PubMed ID: 2852155
[TBL] [Abstract][Full Text] [Related]
16. The long-lasting effect of TU-199, a novel H+, K(+)-ATPase inhibitor, on gastric acid secretion in dogs.
Uchiyama K; Wakatsuki D; Kakinoki B; Takeuchi Y; Araki T; Morinaka Y
J Pharm Pharmacol; 1999 Apr; 51(4):457-64. PubMed ID: 10385219
[TBL] [Abstract][Full Text] [Related]
17. A comparative study on the activity of lansoprazole, omeprazole and PD-136450 on acidified ethanol- and indomethacin-induced gastric lesions in the rat.
Chandranath SI; Bastaki SM; Singh J
Clin Exp Pharmacol Physiol; 2002 Mar; 29(3):173-80. PubMed ID: 11906479
[TBL] [Abstract][Full Text] [Related]
18. Omeprazole prevents indomethacin-induced gastric ulcers in rabbits.
Lee M; Kallal SM; Feldman M
Aliment Pharmacol Ther; 1996 Aug; 10(4):571-6. PubMed ID: 8853761
[TBL] [Abstract][Full Text] [Related]
19. Gastric acid secretion is augmented by the replacement of extracellular Na+ with K+ or other ions.
Akagi K; Hasebe K; Watanabe K; Nagao T; Urushidani T
Jpn J Pharmacol; 1998 Oct; 78(2):147-59. PubMed ID: 9829618
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory action of omeprazole on acid formation in gastric glands and on H+,K+-ATPase isolated from human gastric mucosa.
Elander B; Fellenius E; Leth R; Olbe L; Wallmark B
Scand J Gastroenterol; 1986 Apr; 21(3):268-72. PubMed ID: 3012768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
